Key Events This Week
16 Mar: Downgrade to Sell amid bearish technicals and valuation concerns
17 Mar: Mixed technical signals with mild bullish momentum emerging
18 Mar: Bearish momentum persists amid technical downgrade
19 Mar: Upgrade to Hold on technical and financial improvements
20 Mar: Stock closes the week higher at Rs.4,256.85 (+1.07%)
Sanofi Consumer Healthcare India Ltd Upgraded to Hold on Technical and Financial Improvements
2026-03-19 08:17:47Sanofi Consumer Healthcare India Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, financial performance, valuation metrics, and overall quality. This shift, effective from 18 March 2026, comes amid a backdrop of mixed returns but encouraging quarterly results and evolving market sentiment.
Read full news articleSanofi Consumer Healthcare India Ltd Shows Mixed Technical Signals Amid Mild Momentum Shift
2026-03-19 08:03:25Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend, reflecting a nuanced change in market sentiment. Despite a 2.08% gain on 19 Mar 2026, the stock’s technical indicators present a mixed picture, with some weekly signals turning mildly bullish while monthly trends remain subdued. This article analyses the recent price action, key technical indicators, and the stock’s relative performance against the Sensex to provide a comprehensive view for investors.
Read full news articleSanofi Consumer Healthcare India Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-03-18 08:02:50Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent price action, combined with deteriorating moving averages and mixed momentum oscillators, has prompted a downgrade in its Mojo Grade from Hold to Sell as of 13 March 2026, reflecting growing investor caution in the Pharmaceuticals & Biotechnology sector.
Read full news articleSanofi Consumer Healthcare India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-03-17 08:04:32Sanofi Consumer Healthcare India Ltd has experienced a nuanced shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price momentum and technical indicators reveal a landscape of cautious optimism tempered by lingering bearish undertones.
Read full news articleSanofi Consumer Healthcare India Ltd Downgraded to Sell Amid Bearish Technicals and Valuation Concerns
2026-03-16 08:15:55Sanofi Consumer Healthcare India Ltd has seen its investment rating downgraded from Hold to Sell as of 13 March 2026, driven primarily by deteriorating technical indicators and an expensive valuation despite solid recent financial performance. The company’s small-cap status, coupled with mixed signals across quality, valuation, financial trends, and technicals, has led to a cautious stance from analysts.
Read full news articleSanofi Consumer Healthcare India Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-03-16 08:03:18Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The company’s stock price has declined by 3.14% on the day, reflecting growing investor caution amid weakening technical signals and a recent downgrade in its Mojo Grade from Hold to Sell.
Read full news articleSanofi Consumer Healthcare India Ltd is Rated Sell
2026-03-14 10:10:21Sanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 March 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleWhy is Sanofi Consumer Healthcare India Ltd falling/rising?
2026-03-14 01:19:55
Recent Price Movement and Market Comparison
Sanofi Consumer Healthcare’s stock has been on a downward trajectory for the past three consecutive days, accumulating a loss of 6.56% over this period. The intraday low touched ₹4,174.25, representing a 4.11% decline from the previous close. This underperformance is further highlighted by the stock’s relative weakness compared to its sector, lagging by 1.33% on the day.
When compared to the broader market, the stock’s performance remains subdued. Over the past week, it declined by 4.43%, slightly outperforming the Sensex’s 5.52% fall. However, over the one-month and year-to-date periods, Sanofi Consumer Healthcare’s losses of 1.94% and 6.85% respectively, contrast with the Sensex’s sharper declines of 9.76% and 12.50%. Despi...
Read full news article





